Literature DB >> 29987619

Test-Retest Stability of Cerebral 2-Deoxy-2-[18F]Fluoro-D-Glucose ([18F]FDG) Positron Emission Tomography (PET) in Male and Female Rats.

Jürgen W A Sijbesma1, Aren van Waarde2, David Vállez García3, Hendrikus H Boersma3, Riemer H J A Slart3, Rudi A J O Dierckx3, Janine Doorduin3.   

Abstract

PURPOSE: An important issue in rodent imaging is the question whether a mixed population of male and female animals can be used rather than animals of a single sex. For this reason, the present study examined the test-retest stability of positron emission tomography (PET) with 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) in male rats and female rats at different phases of the estrous cycle. PROCEDURES: Long-Evans rats (age 1 year) were divided into three groups: (1) males (n = 6), (2) females in metestrous (low estrogen levels, n = 9), and (3) females in proestrous (high estrogen levels, n = 7). Two standard [18F]FDG scans with rapid arterial blood sampling were made at an interval of 10 days in subjects anesthetized with isoflurane and oxygen. Body temperature, heart rate, and blood oxygenation were continuously monitored. Regional cerebral metabolic rates of glucose were calculated using a Patlak plot with plasma radioactivity as input function.
RESULTS: Regional metabolic rate of glucose (rCMRglucose) in male and female rats, or [18F]FDG uptake in females at proestrous and metestrous, was not significantly different, but females showed significantly higher standardized uptake values (SUVs) and Patlak flux than males, particularly in the initial scan. The relative difference between the scans and the test-retest variability (TRV) were greater in females than in males. Intra-class correlation coefficients (ICCs) of rCMRglucose, SUV, normalized SUV, and glucose flux were good to excellent in males but poor to moderate in females.
CONCLUSIONS: Based on these data for [18F]FDG, the mixing of sexes in imaging studies of the rodent brain will result in an impaired test-retest stability of PET data and a need for larger group sizes to maintain statistical power in group comparisons. The observed differences between males and females do not indicate any specific gender difference in cerebral metabolism but are related to different levels of non-radioactive glucose in blood plasma during isoflurane anesthesia.

Entities:  

Keywords:  Estrogens; Gender differences; Regional cerebral metabolic rate of glucose; Small animal imaging; Test-retest stability

Mesh:

Substances:

Year:  2019        PMID: 29987619     DOI: 10.1007/s11307-018-1245-4

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  27 in total

1.  A stereotaxic MRI template set for the rat brain with tissue class distribution maps and co-registered anatomical atlas: application to pharmacological MRI.

Authors:  Adam J Schwarz; Anne Danckaert; Torsten Reese; Alessandro Gozzi; George Paxinos; Charles Watson; Emilio V Merlo-Pich; Angelo Bifone
Journal:  Neuroimage       Date:  2006-06-19       Impact factor: 6.556

2.  Sex- and age-related differences in brain FDG metabolism of healthy adults: an SPM analysis.

Authors:  Te-Chun Hsieh; Wan-Yu Lin; Hueisch-Jy Ding; Shung-Shung Sun; Yu-Chin Wu; Kuo-Yang Yen; Chia-Hung Kao
Journal:  J Neuroimaging       Date:  2011-02-18       Impact factor: 2.486

3.  The measurement of observer agreement for categorical data.

Authors:  J R Landis; G G Koch
Journal:  Biometrics       Date:  1977-03       Impact factor: 2.571

4.  Gender differences in correlations of cerebral glucose metabolic rates in young normal adults.

Authors:  N P Azari; S I Rapoport; C L Grady; C DeCarli; J V Haxby; M B Schapiro; B Horwitz
Journal:  Brain Res       Date:  1992-03-06       Impact factor: 3.252

5.  A quantitative method for assessing stages of the rat estrous cycle.

Authors:  C H Hubscher; D L Brooks; J R Johnson
Journal:  Biotech Histochem       Date:  2005 Mar-Apr       Impact factor: 1.718

6.  Gender-related differences in regional cerebral glucose metabolism in normal volunteers.

Authors:  P J Andreason; A J Zametkin; A C Guo; P Baldwin; R M Cohen
Journal:  Psychiatry Res       Date:  1994-02       Impact factor: 3.222

7.  Cerebral glucose metabolic rates in normal human females versus normal males.

Authors:  L R Baxter; J C Mazziotta; M E Phelps; C E Selin; B H Guze; L Fairbanks
Journal:  Psychiatry Res       Date:  1987-07       Impact factor: 3.222

8.  Cognitive-Motor Related Brain Activity During Walking: Differences Between Men and Women With Multiple Sclerosis.

Authors:  Jeffrey R Hebert; John H Kindred; Marco Bucci; Jetro J Tuulari; Lisa A Brenner; Jeri E Forster; Phillip J Koo; Thorsten Rudroff
Journal:  Arch Phys Med Rehabil       Date:  2015-10-09       Impact factor: 3.966

9.  Gender differences of brain glucose metabolic networks revealed by FDG-PET: evidence from a large cohort of 400 young adults.

Authors:  Yuxiao Hu; Qiang Xu; Kai Li; Hong Zhu; Rongfeng Qi; Zhiqiang Zhang; Guangming Lu
Journal:  PLoS One       Date:  2013-12-17       Impact factor: 3.240

10.  A standardized method for the construction of tracer specific PET and SPECT rat brain templates: validation and implementation of a toolbox.

Authors:  David Vállez Garcia; Cindy Casteels; Adam J Schwarz; Rudi A J O Dierckx; Michel Koole; Janine Doorduin
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

View more
  2 in total

Review 1.  Quantitative Rodent Brain Receptor Imaging.

Authors:  Kristina Herfert; Julia G Mannheim; Laura Kuebler; Sabina Marciano; Mario Amend; Christoph Parl; Hanna Napieczynska; Florian M Maier; Salvador Castaneda Vega; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2020-04       Impact factor: 3.488

2.  Comparative test-retest variability of outcome parameters derived from brain [18F]FDG PET studies in non-human primates.

Authors:  Sébastien Goutal; Nicolas Tournier; Martine Guillermier; Nadja Van Camp; Olivier Barret; Mylène Gaudin; Michel Bottlaender; Philippe Hantraye; Sonia Lavisse
Journal:  PLoS One       Date:  2020-10-05       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.